A clinical trail to study the effects of two sensitivity reducing agents in patients with sensitivity

Comparative clinical evaluation of two in-office desensitizing agents in relieving dentin hypersensitivity- a randomized clinical trial - RCTED

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/04/006882

Enrollment

Registered

2016-04-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- DENTINAL HYPERSENSITIVITY Health Condition 2: K038- Other specified diseases of hard tissues of teeth

Interventions

Intervention1: CLINPRO XT VARNISH: Dentin adhesive sealer and is a resin modified glass ionomer cement based varnish. Control Intervention1: SHIELD FORCE PLUS: Dentin adhesive sealer and is a resin ba

Eligibility

Inclusion criteria

Inclusion criteria: 1.Dentinal hypersensitivity caused by attrition, abrasion on any surface of tooth which do not need restorations. 2.Patients without any dental pathology which causes pain similar to dentinal hypersensitivity. 3.Pre-operative VAS score of morethan or equal to 2. 4.Patients in the age group of 18 to 50 years. 5.Patients with good systemic health.

Exclusion criteria

Exclusion criteria: 1.Patients allergic to ingredients used in the study. 2.Teeth with caries, defective restorations, occlusal restorations, chipped teeth. 3.Teeth with deep periodontal pockets (probing depth >6 mm) 4.Patients with ulcerative gingivitis and stomatitis and those who have undergone periodontal surgery within the previous 3 months 5.Subjects with orthodontic appliances 6.Teeth with cervical defects >2mm horizontally 7.Patients who have used desensitizing toothpaste in the last 3 months. 8.Patients who were chronic use of anti-inflammatory andanalgesic medication. 9.Uncontrolled systemic diseases where oral hygiene is concerned. 10.Any gross oral pathology. 11.Uncontrolled systemic diseases where oral hygiene is concerned. 12.Patients who were pregnant or lactating.

Design outcomes

Primary

Measure	Time frame
Post treatment pain evaluation using visual analog scale.Timepoint: pain evaluation 5 minutes after treatment	—

Secondary

Measure	Time frame
post treatment pain evaluation using visual analog scaleTimepoint: pain evaluation 1 week after therapy and 4 weeks after therapy	—

Countries

India

Contacts

Public ContactDr K Madhusudhana MDS

Narayana Dental College and Hospital

lavanyamds@gmail.com9346567413

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026